Physician profile
Imran Arif
NPI 1154380970
$11,854.45
in general payments reported to CMS, 2019-2025
35 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,168 · 2020: $2,067 · 2021: $1,597 · 2022: $1,147 · 2023: $776 · 2024: $780 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,875.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,363.12 | 2019-2024 | Amplatzer Talisman, Diamondback Coronary, Cardiomems |
| Csl Behring | $2,202.64 | 2019 | |
| Edwards Lifesciences Corporation | $1,737.59 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| W. L. Gore & Associates, INC. | $1,401.18 | 2020-2025 | Gore Cardioform Septal Occluder |
| Aop Health US, LLC | $761.18 | 2025 | Rapiblyk |
| Inari Medical, INC. | $518.12 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $448.95 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Boston Scientific Corporation | $275.77 | 2020-2025 | Watchman Access System, Avvigo Guidance System, General - Stents |
| Siemens Medical Solutions USA, INC. | $222.59 | 2020-2022 | |
| Medtronic Vascular, INC. | $190.79 | 2019 | |
| Abiomed | $186.28 | 2024-2025 | Impella |
| Angiodynamics, INC. | $164.67 | 2020-2024 | Alphavac |
| Shockwave Medical, INC | $143.06 | 2021 | |
| Livanova USA, INC. | $109.41 | 2023 | Lifesparc |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.64 | 2019-2024 | Lifevest |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $107.53 | 2022-2025 | |
| Amgen INC. | $95.91 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $83.95 | 2019 | |
| Penumbra, INC. | $81.21 | 2019 | |
| Genzyme Corporation | $79.63 | 2020 | |
| Imperative Care, INC | $77.14 | 2025 | Symphony Catheter |
| Akcea Therapeutics, INC. | $71.88 | 2019 | |
| Medical Device Business Services, INC. | $68.35 | 2023 | Carto 3 |
| Chiesi USA, INC. | $66.91 | 2022-2025 | Kengreal, Juxtapid |
| Cardiva Medical, INC. | $62.85 | 2024-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Stryker Corporation | $50.40 | 2025 | Flowsaver |
| Zoll Circulation INC | $30.41 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.66 | 2024 | Jardiance |
| Endotronix, INC. | $20.90 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Kiniksa Pharmaceuticals International, Plc | $20.70 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $17.58 | 2025 | |
| Thrombolex, INC. | $17.36 | 2024 | Bashir Endovascular Catheter |
| Biotronik INC. | $15.69 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.12 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Arif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.